abstract |
The present invention relates to a pharmaceutical composition comprising a nucleic acid molecule encoding an FGF21 mutant polypeptide, an FGF21 mutant polypeptide, an FGF21 mutant polypeptide, and a nucleic acid, polypeptide, or pharmaceutical composition thereof, Lt; / RTI > |